Journal
BREAST
Volume 22, Issue 2, Pages 109-120Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.breast.2013.01.016
Keywords
Breast cancer; Gene arrays; Gene profiles; Prognostic factors
Categories
Funding
- Breast Journal Club (BJC) Italian Team
Ask authors/readers for more resources
Gene expression profiling tests are used in an attempt to determine the right treatment for the right person with early-stage breast cancer that may have spread to nearby lymph nodes but not to distant parts of the body. These new diagnostic approaches are designed to spare people who do not need additional treatment (adjuvant therapy) the side effects of unnecessary treatment, and allow people who may benefit from adjuvant therapy to receive it. In the present review we discuss in detail the major diagnostic tests available such as MammaPrint dx, Oncotype dx, PAM50, Mammostrat, IHC4, MapQuant DX, Theros-Breast Cancer Gene Expression Ratio Assay, and their potential clinical applications. (C) 2013 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available